Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon R Lewin

Showing results (11-20 of 378) with videos related to

Pageof 38
Sort By:
Current Opinion in HIV and AIDS|March 15, 2016
Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?Thomas A Rasmussen, Sharon R Lewin
The Medical Journal of Australia|April 1, 2019
Reducing the gap between the diagnosis and treatment of HIV infectionKasha P Singh, Sharon R Lewin
Lancet (London, England)|February 23, 2020
Kick and kill for HIV latencySharon R Lewin, Thomas A Rasmussen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Global Challenge Needing More ResearchKasha P Singh, Sharon R Lewin
The Medical Journal of Australia|July 11, 2022
Expanding the toolbox of HIV self-testing at home: the importance of user choice and feedbackDeborah A Williamson, Sharon R Lewin
The Lancet. HIV|March 15, 2020
A cure for HIV: how would we know?Jennifer M Zerbato, Sharon R Lewin
Internal Medicine Journal|January 10, 2018
Towards a cure for human immunodeficiency virusMatthew C Pitman, Sharon R Lewin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
Toll-like Receptor 7 Agonists in People Living With HIV: Implications for Immunotherapeutic Strategies for an HIV CureThomas A Rasmussen, Sharon R Lewin
Current Opinion in HIV and AIDS|April 2, 2020
Editorial: Strategies and barriers for hepatitis B cure: implications for HIVPeter A Revill, Sharon R Lewin
Nature Reviews. Immunology|October 10, 2017
Immune checkpoint blockade in infectious diseasesMichelle N Wykes, Sharon R Lewin
Pageof 38

Showing results (11-20 of 378) with videos related to

Sort By:
Pageof 38
Current Opinion in HIV and AIDS|March 15, 2016
Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?Thomas A Rasmussen, Sharon R Lewin
The Medical Journal of Australia|April 1, 2019
Reducing the gap between the diagnosis and treatment of HIV infectionKasha P Singh, Sharon R Lewin
Lancet (London, England)|February 23, 2020
Kick and kill for HIV latencySharon R Lewin, Thomas A Rasmussen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Global Challenge Needing More ResearchKasha P Singh, Sharon R Lewin
The Medical Journal of Australia|July 11, 2022
Expanding the toolbox of HIV self-testing at home: the importance of user choice and feedbackDeborah A Williamson, Sharon R Lewin
The Lancet. HIV|March 15, 2020
A cure for HIV: how would we know?Jennifer M Zerbato, Sharon R Lewin
Internal Medicine Journal|January 10, 2018
Towards a cure for human immunodeficiency virusMatthew C Pitman, Sharon R Lewin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
Toll-like Receptor 7 Agonists in People Living With HIV: Implications for Immunotherapeutic Strategies for an HIV CureThomas A Rasmussen, Sharon R Lewin
Current Opinion in HIV and AIDS|April 2, 2020
Editorial: Strategies and barriers for hepatitis B cure: implications for HIVPeter A Revill, Sharon R Lewin
Nature Reviews. Immunology|October 10, 2017
Immune checkpoint blockade in infectious diseasesMichelle N Wykes, Sharon R Lewin
Pageof 38